A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

NCT05644977 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
Alzheimer's Disease Dementia

Interventions

DRUG: Emraclidine
DRUG: Placebo

Sponsor

AbbVie